A Single-center Phase I Clinical Study Evaluating the Pharmacokinetics and Safety of Single and Multiple Oral Administration of Narfurine Hydrochloride Orally Disintegrating Tablets in Chinese Healthy Adult Subjects
Latest Information Update: 07 Jun 2022
At a glance
- Drugs Narfurine Hydrochloride (Primary)
- Indications Pruritus
- Focus Adverse reactions; Pharmacokinetics
- 07 Sep 2020 Status changed from recruiting to active, no longer recruiting.
- 16 Jun 2020 New trial record
- 01 Jun 2020 Status changed from not yet recruiting to recruiting.